Literature DB >> 30942194

Atrial electrical remodeling induced by chronic ischemia and inflammation in patients with stable coronary artery disease.

Răzvan Constantin Serban1, Alkora Ioana Balan2, Marcel Perian2, Irina Pintilie3, Cristina Somkereki1, Adina Huţanu4, Alina Scridon4.   

Abstract

The pathophysiology of coronary artery disease (CAD) includes low-grade chronic inflammation. At its turn, inflammation is known to promote myocardial structural remodeling and to increase vulnerability to atrial arrhythmias. Meanwhile, the impact of chronic inflammation on the electrophysiological properties of the atria remains unknown. We aimed to evaluate the impact of low-grade chronic inflammation on atrial electrophysiology in patients with stable CAD undergoing elective coronary artery bypass grafting (CABG). Circulating levels of several inflammatory, angiogenesis, and endothelial dysfunction markers were determined 1 day before CABG in 30 consecutive CAD patients. Right atrial appendage samples were collected during the CABG procedure; action potential recordings were performed in six study patients using the microelectrode technique. Interleukin (IL)-1b (r = 1.00, P = 0.01), IL-6 (r = 0.98, P < 0.01), vascular endothelial growth factor (VEGF) (r = 0.98, P < 0.01), and hemoglobin (r = 0.98, P < 0.01) levels significantly positively correlated with the duration of atrial depolarization. Consequently, IL-6, VEGF, and hemoglobin (r = -0.86, P = 0.03 for all) levels significantly negatively correlated with the velocity of atrial depolarization. There was no significant correlation between any of the studied markers levels and any of the other parameters of the action potential (all P > 0.05). The present study is the first to demonstrate that in patients with stable CAD, chronic inflammation and ischemia are associated with pro-arrhythmic atrial electrical remodeling. These changes may contribute to the increased propensity to postoperative atrial arrhythmias seen in some of the patients undergoing CABG.

Entities:  

Keywords:  Action potential; coronary artery bypass grafting; inflammation; ischemia; pro-arrhythmic electrical remodeling

Mesh:

Substances:

Year:  2019        PMID: 30942194     DOI: 10.4103/CJP.CJP_2_19

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  4 in total

Review 1.  Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines.

Authors:  Savalan Babapoor-Farrokhran; Deanna Gill; Jafar Alzubi; Sumeet K Mainigi
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

2.  Focal atrial tachycardia-the localization differences between men and women: A study of 487 consecutive patients.

Authors:  Yusuf Turkmen; Per Insulander; Hamid Bastani; Nikola Drca; Ott Saluveer; Jari Tapanainen; Tara Bourke; Göran Kennebäck; Jonas Schwieler; Frieder Braunschweig; Mats Jensen-Urstad
Journal:  Anatol J Cardiol       Date:  2020-12       Impact factor: 1.596

Review 3.  Targeting necroptosis as therapeutic potential in chronic myocardial infarction.

Authors:  Chanon Piamsiri; Chayodom Maneechote; Natthaphat Siri-Angkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Biomed Sci       Date:  2021-04-09       Impact factor: 8.410

Review 4.  Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction-Promises and Challenges.

Authors:  Ioan Tilea; Andreea Varga; Razvan Constantin Serban
Journal:  Diagnostics (Basel)       Date:  2021-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.